Seres Therapeutics, Inc., was incorporated in October 2010 under the laws of the State of Delaware. The Company is a commercial-stage microbiome therapy company focused on the development and commercialization of a new class of biopharmaceuticals designed to treat disease by modulating the microbiome and restore health by repairing the function of the disrupted microbiome to a non-disease state. The company is also designing microbiome therapies that are optimized to de-colonize pathogens and modulate host function to reduce and prevent infection and induce immune tolerance. 

MCRB

MCRB Profile